Recently, an approach to reduce TN-C in the tumor stroma of pancreatic cancer involved interfering with the aberrant cancer cell-mesenchymal crosstalk, which is required for stellate cell activation (161). This evidence concerns the gene TNC and pancreatic neoplasm.